FDA Validates Use of Amgen’s KRAS Inhibitor in Lung Cancer In a pathbreaking move, Amgen has gone ahead to emerge as a trailblazer in the undruggable lung cancer space with the approval of its KRAS inhibitor, Lumakras. For eons, the researchers grappled to come up with an effective and potential drug to ta...Find More
Gene Therapy: The “Key” to Dermatological disorders! About Dermatological disorders Dermatological disorders comprises of diseases of the skin, scalp, hair, and nails. Apart from being the largest organ in the body, the skin has a vital social function and relatively minor skin complaints often cause more anguish ...Find More
The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.